CLASS II ONGOING Device recall · Reported 10 Apr 2024 · FDA Enforcement Report

Ureteral dilator recalled by Coloplast Manufacturing US

Coloplast Manufacturing US is recalling Ureteral dilator, distributed in 9 states. The recall was initiated on 11 Mar 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 03600040300503, Lot codes: 6885096, 6928493, 7036982, 7092593, 7148682, 7187751, 7275918, 7326750, 7362229, 7405815, 7424892, 7440816, 7459583, 7528743, 7575957, 7742150, 7806993, 7825256, 7874646, 7948615, 8050730, 8122897, 8174950, 8210399, 8313229, 8350283, 8359041, 8442175, 8519426, 8619976, 8700201, 8864944, 8946228, 8946264, 9122793, 9122794, 9168554, 9226390, 9246177, 9360599
Quantity recalled710 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1463-2024
FDA event ID
94218
Recalling firm
Coloplast Manufacturing US, Minneapolis, MN
Classification
Class II
Status
Ongoing
Recall initiated
11 Mar 2024
FDA classified
2 Apr 2024
Reported
10 Apr 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

11 Mar 2024Recall initiated by company
2 Apr 2024Classified by FDA+22 days
10 Apr 2024Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A possible sterility issue (e.g. a breach in sterile packaging) was detected in Coloplast's facility on some ureteral dilator products. This issue on the ureteral dilator packaging has been identified during testing in our facility.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Ureteral dilator, REF RBD014

Where it was distributed

US: GA, MS, TN, MN, AZ,N MD, LA, KS, WA

ArizonaGeorgiaKansasLouisianaMarylandMinnesotaMississippiTennesseeWashington

Questions about this recall

Why was it recalled?

A possible sterility issue (e.g. a breach in sterile packaging) was detected in Coloplast's facility on some ureteral dilator products. This issue on the ureteral dilator packaging has been identified during testing in our facility.

Which lots are affected?

UDI-DI: 03600040300503, Lot codes: 6885096, 6928493, 7036982, 7092593, 7148682, 7187751, 7275918, 7326750, 7362229, 7405815, 7424892, 7440816, 7459583, 7528743, 7575957, 7742150, 7806993, 7825256, 7874646, 7948615, 8050730, 8122897, 8174950, 8210399, 8313229, 8350283, 8359041, 8442175, 8519426, 8619976, 8700201, 8864944, 8946228, 8946264, 9122793, 9122794, 9168554, 9226390, 9246177, 9360599

Where was it sold?

US: GA, MS, TN, MN, AZ,N MD, LA, KS, WA

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Coloplast Manufacturing US

All 28

Other Other Medical Devices recalls

All 13,908